Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Thermo Fisher Supplies Analytical Instruments to World Anti-Doping Agency Laboratory in South Korea

Thermo Fisher
Posted on: 28 Feb 18

WALTHAM, Mass., Feb. 28, 2018 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, today announced that its High Performance Liquid Chromatography and Mass Spectrometry instrumentation has been used by Korea Institute of Science and Technology's Doping Control Center, a World Anti-Doping Agency (WADA)-accredited laboratory responsible for screening and identifying banned substances in athletes from around the globe during a major sport event in South Korea.

Based in Seoul, South Korea, the Doping Control Center conducted prohibited substance screening using Liquid Chromatography-Mass Spectrometry (LC-MS) and isotope ratio mass spectrometry (IRMS) workflows. Instruments included:

Thermo Scientific TSQ Altis triple quad mass spectrometers designed to screen against the WADA-prohibited list of compounds.

Thermo Scientific Q Exactive Plus Orbitrap-based mass spectrometers designed to confirm the presence of banned compounds using high-resolution Orbitrap mass spectrometry.

Thermo Scientific Delta V Isotope Ratio mass spectrometers designed for exogenous/endogenous steroid analysis.

The Thermo Scientific Vanquish UHPLC platform, Thermo Scientific UltiMate 3000 RSLCnano system, and Thermo Scientific UltiMate 3000 Binary Semi-preparative system used with mass spectrometers and designed for purifying compounds prior to IRMS analysis.

In addition, Unity Lab Services in South Korea provided on-site technical and application support. Over the course of six weeks, the Doping Control Center has run several thousand tests using Thermo Scientific instruments.

"The high-end technologies of Thermo Fisher, combined with their service expertise, have been vital in the prohibited substance screening process," said Dr. Oh-Seung Kwon, Lab Director of the Doping Control Center, Korea Institute of Science and Technology (KIST).     

"We are excited to provide our innovative screening solutions, as well as on-site technical and application support, to the Doping Control Center during this important event," said Jakob Gudbrand, president, chromatography and mass spectrometry, Thermo Fisher Scientific.

Thermo Fisher provides laboratories with support in and out of competition testing with high-throughput instruments for screening large sets of compounds efficiently in a single methods approach. The company offers chromatography consumables and mass spectrometry–based solutions that demonstrate analytical specificity, sensitivity, and dynamic range in terms of concentration and number of drugs monitored for quantitative analysis.

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of more than $20 billion and approximately 70,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive services. For more information, please visit www.thermofisher.com.

Media Contact Information:

Marcia Goff                                                                             
Thermo Fisher Scientific                                                           
+1 781-622-1248
marcia.goff@thermofisher.com

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 28/02/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.